Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP) - Wikidata - awgldk - TriplyDB

Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)

Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)

http://www.wikidata.org/entity/Q27641642

about

Research progress on Livin protein: an inhibitor of apoptosis Structures of BIR domains from human NAIP and cIAP2 Targeting Cell Survival Proteins for Cancer Cell Death Crystal Structure of the BIR1 Domain of XIAP in Two Crystal Forms The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP) †Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)The structure of XIAP BIR2: understanding the selectivity of the BIR domains Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor Phage display of random peptide libraries: applications, limits, and potential.Amsacta moorei Entomopoxvirus inhibitor of apoptosis suppresses cell death by binding Grim and Hid Peptide aptamers: recent developments for cancer therapy.The mechanism of peptide-binding specificity of IAP BIR domains.Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade Targeting protein-protein interactions as an anticancer strategy Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas Synthetic mimetics of protein secondary structure domains Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain.Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.IAP proteins as targets for drug development in oncology Small-molecule pan-IAP antagonists: a patent review.Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.Targeting inhibitor of apoptosis proteins for therapeutic intervention.Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.NAIPs: building an innate immune barrier against bacterial pathogens. NAIPs function as sensors that initiate innate immunity by detection of bacterial proteins in the host cell cytosol.Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.Development of Peptidomimetics Targeting IAPs The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein.Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.

P2860

Q24304472-336114FA-0F93-42AA-B54C-79503AD52050 Q24656690-2BAB649A-EC3F-48CD-A895-EBEB8423DFF0 Q26765447-515D7CF0-620B-4154-8A41-E8FED7C8DBF3 Q27647264-90434CD8-33A6-4B56-878F-F2ED147C6F8B Q27648318-D09E13C8-DBE1-41C1-981F-F981B4F04DDE Q27652682-40833D9E-1C68-4452-9C1F-C5A8D2A35339 Q27678027-7B16EEA8-3B38-40A8-9386-928922CF3CD3 Q27679855-E3E12A2B-E1AC-4B3F-9262-79AD40D24697 Q27680601-832048EE-71B3-4F81-ABF2-542866ADF7E1 Q31039269-90C6A295-F239-469A-A464-AD858D16BC4C Q31149866-E7ECC1A5-F8BF-4170-B1D3-F97AEDC20C1C Q33216999-18174CDC-C5A5-4725-93E0-56C63FB6A353 Q33317750-BBAFCC0A-0706-46D2-BBB1-53277DD728AF Q33327051-F6564C0B-6F5B-45BE-B5C2-909FDA99396A Q34347892-11833521-AD57-4C44-8C65-BF8173DD4B31 Q35588764-9E69EB46-8416-46CC-B559-AC740A00F780 Q35688001-7E39A3CF-F91D-4046-97A1-E921D1785B12 Q36491838-7768AB63-A0B9-423B-B65E-6E4101D5F18C Q36611508-27C8B0D1-7BDB-4EB8-B277-23AF66684AD3 Q37209606-8287EA1B-42EC-4AE9-AAA7-F40B1247AAD5 Q37680967-C3FC57E4-37BF-493E-8C04-6590D269729B Q37705961-2827FB50-5B73-4F71-99C9-FD6AFC3409FB Q37855868-BFF1B5E1-FAAF-4A0F-AF6B-A0F8C81AAFEC Q37875078-01F7E4ED-6B74-421C-9C2D-519409531DD0 Q38003578-C3833F45-5A40-4154-9D28-469C62FC552C Q40504409-0F4F93A3-DE43-431D-A861-814AE59EE96D Q40504414-1AA72EAA-36EB-4388-BC23-CAAA8534D2D2 Q41911916-5E0B5AF0-A3E4-413F-957C-5E99DD0D97C5 Q46200610-9E9B938A-4A60-46A0-8AF6-3DE783F84724 Q46857204-E7473702-B124-4A3B-814B-4568F287BE46 Q50674825-6F46653E-DEBD-4769-A2BE-D1846742A4A4 Q51746852-0683228E-6217-4243-B847-4FF660D6DB9B

P2860

Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)

http://www.wikidata.org/entity/Q27641642

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@ast

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@en

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@nl

type

label

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@ast

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@en

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@nl

prefLabel

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@ast

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@en

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@nl

P1433

Q27641642-7AF2C6A8-1F57-4E11-8CEC-F678BB09F1A0

P1476

Q27641642-A514BEDF-3A6B-41F4-A61F-2DB79044BFAE

P2093

Q27641642-49871F19-D94E-4F75-8A9B-FC600ACA6C65

Q27641642-4E03CF1C-75BB-42A5-8C28-5DD8E4F4521D

Q27641642-6C7478C4-1C85-4222-997E-EB061EA7DDE0

Q27641642-7370C529-D657-4E73-A3DD-A6E7D777F229

Q27641642-92C81214-C1B8-45C7-80DB-C98D3BC995A0

Q27641642-94651619-4458-4F9F-8833-77CE7E8598E5

Q27641642-A08F21EF-56DC-4D8E-9922-BAD7536136CE

Q27641642-ACDBE16E-B147-4DF8-9B6D-801B203153F8

Q27641642-B5B06DF6-9F18-46D4-9B66-6175882C6F96

Q27641642-C55F0269-CD87-4C95-A45B-2027A99357F0

P304

Q27641642-FF81348A-8F73-47F8-AE70-8AA84A84CEBE

P31

Q27641642-D1F6E236-0AD7-4B9E-A242-F4DC043DEF3C

P356

Q27641642-1CB824F4-A489-4DE9-9093-17A346A1C1F4

P407

Q27641642-E3A646A8-13C0-4298-B755-DDAC18ACEF39

P433

Q27641642-C89011B3-8F12-4749-8E62-C726EF1E05C7

P478

Q27641642-926F6901-1117-4859-A6C3-DF826DBFF6EB

P577

Q27641642-8CDA7C85-85AC-4CA0-87CF-26D64B8DD5CF

P5875

Q27641642-4AC6227C-DEE8-476B-A307-B1A30C7C43FD

P698

Q27641642-945B417A-2CAE-47C8-B0C8-C544DC46F103

P921

Q27641642-D53CE57D-ECD6-4AF5-9F9A-21B82CA4AE0B

P356

P1433

P1476

Structure and function analysi ...... nhibitor of apoptosis (ML-IAP)

@en

P2093

Daniela Alexandru

http://www.w3.org/2001/XMLSchema#string

Danny Ong

http://www.w3.org/2001/XMLSchema#string

David C Okawa

http://www.w3.org/2001/XMLSchema#string

Domagoj Vucic

http://www.w3.org/2001/XMLSchema#string

Grace Mausisa

http://www.w3.org/2001/XMLSchema#string

Heidi Ackerly

http://www.w3.org/2001/XMLSchema#string

John A Flygare

http://www.w3.org/2001/XMLSchema#string

Kurt Deshayes

http://www.w3.org/2001/XMLSchema#string

Linda O Elliott

http://www.w3.org/2001/XMLSchema#string

Mark D Distefano

http://www.w3.org/2001/XMLSchema#string

P304

8223-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BI034227T

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10673433

http://www.w3.org/2001/XMLSchema#string

P698

12846571

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process